Michael Bokoch
Has grant
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Endothelial Activation by Liver Reperfusion Injury in Transplantation
Open Date: 2020-07-01
Close Date: 2022-06-30
Articles (21)
Year:
2026
Year:
2026
General anesthetics are essential for invasive medical procedures; however, there remains a need for safer agents. Using a bespoke 96-well-plate format platform enabling high-throughput imaging of larval zebrafish behavior, we screened 12,000 compounds and identified an isoxazole chemotype that phenocopies the intravenous anesthetics etomidate and propofol. Its optimization via medicinal chemistry yielded a novel anesthetic that we call nidradine. This anesthetic is efficacious in both zebrafish and mice and lacks the problematic adrenal suppression characteristic of etomidate. Mechanistic studies via electrophysiology and structural biology revealed that nidradine, like etomidate and propofol, is a positive allosteric modulator of the GABA A receptor. Remarkably, behavioral assays in mice demonstrate that nidradine differs from most general anesthetics in that it also produces analgesia.
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Background. Early extubation after liver transplantation can decrease cost and intensive care unit lengths of stay, but its adoption remains limited because of safety concerns. We assessed the feasibility and safety of early extubation at a liver transplant center with a high early extubation rate. We analyzed subgroups of high-risk patients, including high model for end-stage liver disease-sodium (MELD-Na) score, high intraoperative blood loss, and patients undergoing simultaneous liver-kidney transplantation. Methods. We included all adult liver transplantations performed at a single center between June 2012 and July 2022. Patients were divided into 2 groups: (1) those extubated early (ie, in the operating room or within the first hour of intensive care unit admission) and (2) those who underwent delayed extubation. The primary outcome was reintubation within 48 h after early extubation. Rates of early extubation were analyzed separately for quartiles of MELD-Na score and intraoperative blood loss. Results. Of 1555 patients, 969 (62%) were extubated early. Of these, 31 patients (3.2%) required mechanical ventilation within 48 h postoperatively: 11 patients (1.1%) were reintubated for respiratory failure and 20 (2.1%) remained intubated after reoperation. There was no difference in postoperative pneumonia between the groups ( P = 0.059). Early extubation rates inversely correlated with the quartiles of MELD-Na score and estimated blood loss. In the highest quartile for MELD-Na (>34) and estimated blood loss (>5 L), 34% of patients were extubated early. Conclusions. Early extubation of properly selected patients after liver transplantation is safe and associated with a low rate of reintubation, even among select groups of high-risk patients.
Year:
2025
Acute kidney injury is a common complication after liver transplantation. Acute kidney injury occurrence in this population determines higher mortality, increased graft loss, longer hospital and intensive care unit stays, and more progression to chronic kidney disease. Hemodynamic derangements are treated intraoperatively with vasopressor medications to uphold a mean arterial pressure within the autoregulatory range of the kidney, but the impact of their use, as well as the choice of medication, on postoperative kidney function, is relatively unknown. Vasopressin acts as a portal flow modulator, has a potential catecholamine-sparing effect, and provides benefits for kidney function during distributive shock. The investigators hypothesized that the intraoperative use of vasopressin could reduce the incidence of postoperative severe acute kidney injury after liver transplantation and planned a retrospective single-center propensity score-adjusted regression analysis to test this hypothesis.
Year:
2024
Sera from patients in our UCSF Liver Transplant Biobank are used to stimulate human pulmonary microvascular endothelial cells (HPMECs) grown to confluency on ECIS platform. This protocol prospectively defines the plan for data analysis from these experiments.
Year:
2024
Sera from patients in our UCSF Liver Transplant Biobank are used to stimulate human pulmonary microvascular endothelial cells (HPMECs) grown to confluency on ECIS platform. This protocol prospectively defines the plan for data analysis from these experiments.
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (12)
Brian K. Shoichet
University of California, San Francisco
Hillary Braun
Assistant Professor
University of California, San Francisco
Matthieu Legrand
Prof
UCSF Medical Center
Matthew McCarroll
Professional Researcher
University of California, San Francisco
Elizabeth Whitlock
Associate Professor
UCSF Medical Center
Allan Basbaum
University of California
Ryan Hibbs
Professor
University of California, San Diego
Oliver Kimberger
Deputy Head of Department (Geschäftsführender Oberarzt)
Medical University of Vienna
Dieter Adelmann
Associate Professor
University of California, San Francisco
Garrett Roll
Associate Professor of Surgery
University of California, San Francisco
Kerstin Kolodzie
University of California, San Francisco
Michael Mathis
Associate Professor
University of Michigan
Make your next move.
Prepare your application
Review drafts before you send them.